EL7.AI
Mergers & AcquisitionsMedium•2 November 2026•
4 min read

Kimberly-Clark Completes Kenvue Deal, Adding a Portfolio of 10 Billion-Dollar Brands

Key Facts

1Kimberly-Clark completed its acquisition of Kenvue on November 2, 2026, and Kenvue became a wholly owned subsidiary.
2The company is targeting about $1.9 billion in cost savings over 3 years and about $500 million in additional earnings over 4 years, with $300 million reinvested.
3The announced consideration for Kenvue shareholders was $21.01 per share, in cash and stock, based on Kimberly-Clark's share price on October 31, 2025.
4The company estimated the group's annual net sales at about $32 billion and adjusted earnings before interest, taxes, depreciation and amortization at about $7 billion for 2025.
5Final results for the third quarter of 2026 are scheduled for release on November 5.

Kimberly-Clark completed its acquisition of Kenvue on November 2, 2026, making Kenvue a wholly owned subsidiary, according to the company's filing with the U.S. Securities and Exchange Commission. The closing ends the deal phase announced by the two companies in 2025 and opens a period for management to integrate the businesses and deliver the financial benefits it projected. Kimberly-Clark said when it announced the deal that the combined portfolio would include 10 brands each with more than $1 billion in sales. The companies' portfolios span complementary categories in consumer health and personal care, according to the company. Kimberly-Clark presented the new group as a candidate to become “the world's leading consumer health and wellness company,” a characterization from the company rather than an outcome achieved simply by completing the acquisition.

The deal's stated financial rationale centers on cost cuts and increased earnings from revenue, but the figures remain forward-looking targets. Kimberly-Clark expects to achieve about $1.9 billion in cost savings during the first three years after closing. It is also targeting about $500 million in additional earnings from revenue synergies over four years. The company estimated that reinvesting about $300 million would offset part of these benefits. The figures therefore do not represent a single net estimate attributable to a specific fiscal year: the time frames differ for each item, and the savings and additional revenue have not yet translated into actual results.

Achieving the targets will require substantial cash spending during integration. Kimberly-Clark expected to incur $2.5 billion in cash costs to deliver the savings, to be invested during the first two years after closing. This places implementation costs alongside the savings the company said it would pursue later in the deal's financial picture. The company had also expected the deal to be accretive to adjusted earnings per share by the second year after closing. That means its stated timing for earnings accretion comes before the end of the four-year period set for revenue-synergy earnings, while the cost-savings plan spans the first three years.

When it announced the deal, Kimberly-Clark estimated the combined group's annual net sales at about $32 billion and adjusted earnings before interest, taxes, depreciation and amortization at about $7 billion, based on 2025 estimates. These figures remain forecasts disclosed when the deal was announced, not operating results for the group after closing. The company valued Kenvue on an enterprise-value basis at about $48.7 billion, using Kimberly-Clark's closing share price on October 31, 2025. The announced consideration for Kenvue shareholders was $3.50 in cash and 0.14625 Kimberly-Clark shares for each Kenvue share. The announced total value was $21.01 per share, calculated using Kimberly-Clark's closing share price on that date.

Under the ownership structure expected at closing on a fully diluted basis, existing Kimberly-Clark shareholders were expected to own about 54% of the combined company, compared with about 46% for Kenvue shareholders. Mike Hsu will serve as chairman and chief executive of the group, according to Kimberly-Clark's announcement. The company also said its headquarters would remain in Irving, Texas. The closing followed approval by shareholders of both companies of the deal-related proposals at special meetings on January 29, 2026. The waiting period under U.S. antitrust law expired on February 4, 2026, according to Kimberly-Clark's quarterly filing.

EL7 data show Kimberly-Clark shares closed at $107.94 and Kenvue shares at $19.31 on October 30, 2026, the last closing prices before the deal completion date stated in the filing. These prices alone do not measure the effect of the announcement or closing on the two shares' performance. In September 2026, Kimberly-Clark began exchange offers for Kenvue notes that included issuing new Kimberly-Clark notes with an aggregate principal amount of up to $7 billion, subject to completion of the acquisition. A company filing also said a $7.7 billion bridge financing commitment was intended to fund the cash consideration and deal expenses, among other uses. The next corporate milestone comes on November 5, when Kimberly-Clark said it would release its final results for the third quarter of 2026.

The company has also tied execution monitoring to the division of responsibilities within its executive team. In October, it said Ross Torres, its president and chief operating officer and head of the Integration Management Office, would leave to become chief executive of another organization. It added that he would stay through November to support a smooth transition, a timeline that overlaps with the first weeks after the deal's completion. Kimberly-Clark assigned chief financial officer Nelson Ordianeta to oversee plans to deliver the savings. The November 5 results will therefore be the first announced near-term date for reporting quarterly results, while integration and savings targets remain spread across periods ranging from the first two years to the four years after closing.

Open on chart